Hana Kostrhunova

Hana Kostrhunova

Auto-generated profile, based on publicly available information

Hana Kostrhunova

Czech Academy of Sciences, Institute of Biophysics, CZ-61200 Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2021 in Inorganic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
GVGloria Vigueras
Gloria Vigueras
LMLenka Markova
Lenka Markova
VNVojtech Novohradsky
Vojtech Novohradsky
AMAlicia Marco
Alicia Marco
NCNatalia Cutillas
Natalia Cutillas
Viktor BrabecViktor Brabec
Viktor Brabec
Several anticancer chemotherapies, while eliminating the bulk of tumor cells, often fail, as they do not obliterate a small fraction of malignant cancer stem cells (CSCs). Thus, developing chemotherapeutics capable of targeting and abrogating CSCs, including inducing immunogenic cell death in CSCs, is essential for developing new anticancer drugs. Herein, we report octahedral Ir(III) complexes based on a benzimidazole backbone containing NH groups. The complexes exhibit low toxicity in the dark against human skin melanoma cells and high phototoxicity with blue light irradiation under both normoxic and hypoxic conditions. Additionally, complex 4 induces secretion of damage-associated molecular patterns characteristic of immunogenic cell death (ICD) in melanoma cells when the cells are irradiated with blue light. The results also suggest that the mechanism of the ICD induced by this complex may involve oxidative damage of intracellular targets by photoinduced ROS generation. This property of 4 may allow targeting the photochemotherapy based on 4 selectively to the tumor.

30 July 2019 in Inorganic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
VNVojtech Novohradsky
Vojtech Novohradsky
GVGloria Vigueras
Gloria Vigueras
JPJitka Pracharova
Jitka Pracharova
NCNatalia Cutillas
Natalia Cutillas
Christoph JaniakChristoph Janiak
Christoph Janiak
JKJana Kasparkova
Jana Kasparkova
The phototoxicity in cancer cells of three series of octahedral Ir(III) complexes of the general formula [Ir(C^N)2(N^N)][PF6], where the N^N ligand is dipyrido[3,2-a:2′,3′-c]phenazine (dppz) and the C^N ligands are deprotonated 2-phenyl-, 2-(naphthalen-2-yl)- or 2-(thiophen-2-yl)-benzimidazole derivatives (series 1, 2 and 3, respectively) with different substituents (H, methyl or 4-(trifluoromethyl)benzyl) on the imidazole units, has been studied. The 1-methyl benzimidazole compounds 2b and 3b were found to be the most photoactive in model human cervical cancer HeLa cells (IC50 about 20 nM under irradiation conditions, λexc = 420 nm), inducing a substantial formation of apoptotic bodies as shown by flow cytometry, whereas the 4-(trifluoromethyl)benzyl derivatives 1c–3c showed the highest phototoxic indexes of the three series. Notably, the antiproliferative activity of the photoactivated Ir(III) compounds was also significant under hypoxic conditions (2% O2). Fluorescence confocal microscopy investigation for 1c, 2c and 3c was undertaken, showing a significant subcellular localization of 3c in mitochondria, whereas 1c and 2c were located preferentially in the endoplasmic reticulum (ER). Further investigations on series 3 compounds using CellRox® (oxidative stress deep red reagent) have shown, after pretreatment with Tiron, that molecular superoxide radical (O2˙−) generation is mainly responsible for the oxidative stress induced by irradiation of the cells treated with the 2-(thiophen-2-yl)benzimidazole derivatives 3a–c. The photopotentiation of 3a and 3c also involves the formation of singlet oxygen (1O2), but this does not occur with 3b, due to pretreatment with sodium azide. The ROS generation was also studied by standard droethidium (DHE) and singlet oxygen sensor green (SOSG) staining assays under both normoxic and hypoxic conditions. The results showed that in tumor HeLa cells, the generation of superoxide radicals competed with singlet oxygen production in cells in normoxia, but became dominant under hypoxia.

12 September 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
ASAmrita Sarkar
Amrita Sarkar
VNVojtech Novohradsky
Vojtech Novohradsky
MMMoumita Maji
Moumita Maji
TBTomer Babu
Tomer Babu
LMLenka Markova
Lenka Markova
DGDan Gibson
Dan Gibson
A multitargeting prodrug (2) that releases gemcitabine, oxaliplatin, and doxorubicin in their active form in cancer cells is a potent cytotoxic agent with nM IC50s; it is highly selective to cancer cells with mean selectivity indices to human (136) and murine (320) cancer cells. It effectively induces release of DAMPs (CALR, ATP & HMGB1) in CT26 cells facilitating more efficient phagocytosis by J774 macrophages than the FDA drugs or their co‐administration. The viability of CT26 cells co‐cultured with J774 macrophages and treated with 2 was reduced by 32 % compared to the non‐treated cells, suggesting a synergistic antiproliferative effect between the chemical and immune reactions. 2 inhibited in vivo tumor growth in two murine models (LLC and CT26) better than the FDA drugs or their co‐administration with significantly lower body weight loss. Mice inoculated with CT26 cells treated with 2 showed slightly better tumor free survival than doxorubicin.

4 August 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
HKHana Kostrhunova
Hana Kostrhunova
JZJuraj Zajac
Juraj Zajac
LMLenka Markova
Lenka Markova
Viktor BrabecViktor Brabec
Viktor Brabec
JKJana Kasparkova
Jana Kasparkova

10 February 2019 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
HKHana Kostrhunova
Hana Kostrhunova
EPEmanuele Petruzzella
Emanuele Petruzzella
DGDan Gibson
Dan Gibson
JKJana Kasparkova
Jana Kasparkova
Viktor BrabecViktor Brabec
Viktor Brabec

1 January 2022 in Bioinorganic Chemistry and Applications
Verified
Journal Article
Open access
PDF file
MHMonika Hreusova
Monika Hreusova
VNVojtech Novohradsky
Vojtech Novohradsky
LMLenka Markova
Lenka Markova
HKHana Kostrhunova
Hana Kostrhunova
IPIvan Potočňák
Ivan Potočňák
JKJana Kasparkova
Jana Kasparkova
In this work, gallium(III) complex with cloxyquin (5‐chloro‐8‐quinolinol, HClQ) ligands is shown to effectively inhibit proliferation of rhabdomyosarcoma cells, the frequent, aggressive, and poorly treatable cancer of children. It offers striking selectivity to cancer cells compared to noncancerous human fibroblasts. The data reveal that the complex induces ferroptosis in rhabdomyosarcoma cells, likely due to interfering with iron metabolism. Importantly, it can kill both bulk and stem rhabdomyosarcoma cells. To the best of our knowledge, this is the first compound based on metal other than Fe capable of inducing ferroptosis in cancer cells.